|
Profit before tax rose 28.95% to Rs 8.73 crore as against Rs 6.77 crore posted in the same quarter previous year.
Operating EBITDA grew 24% to Rs 11.36 crore in the quarter ended 30 June 2023 from Rs 9.19 crore reported in Q3 FY22, due to healthy growth in overall sales.
The company's revenue from Animal Healthcare segment stood at Rs 22.46 crore (up 93% YoY) while revenue from Poultry Healthcare division was at Rs 30.28 crore (down 13% YoY) during the quarter.
Hester is one of the leading poultry and animal healthcare companies in India. It is the second largest poultry vaccine manufacturer in India. It currently has a 75% market share in PPR vaccines for Sheep and Goat, across the world. In addition, the company has a health products portfolio comprising of therapeutics, feed supplements and biosecurity.
|